# The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease

> **NCT01548014** · PHASE3 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 1 (estimated)

## Conditions studied

- Crohn's Disease

## Interventions

- **DIETARY_SUPPLEMENT:** VSL#3

## Key facts

- **NCT ID:** NCT01548014
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2012-09
- **Final completion:** 2016-01
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2012-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01548014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01548014, "The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01548014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*